STOCK TITAN
  1. Home
  2. Sec-filings
  3. EXOZ
  4. [EFFECT] EXOZYMES INC. SEC Filing

[EFFECT] EXOZYMES INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 23, 2026 4:30 P.M.
Form: S-3
CIK: 0002010788
Company Name: EXOZYMES INC.
File Number: 333-292781

Source: View Original Filing on SEC EDGAR

Stock EXOZ logo
eXoZymes Inc

NASDAQ:EXOZ

EXOZ Rankings

#5052 Ranked by Market Cap
N/A Ranked by Dividends

EXOZ Latest News

Dec 11, 2025
eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion
Nov 13, 2025
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
Nov 13, 2025
eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff
Nov 10, 2025
eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST
Oct 30, 2025
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

EXOZ Latest SEC Filings

Jan 16, 2026
[S-3] EXOZYMES INC. Shelf Registration Statement
Dec 16, 2025
[S-8] EXOZYMES INC. Employee Benefit Plan Registration
Dec 11, 2025
[8-K] EXOZYMES INC. Reports Material Event
Nov 13, 2025
[10-Q] EXOZYMES INC. Quarterly Earnings Report
Nov 13, 2025
[8-K] EXOZYMES INC. Reports Material Event

EXOZ Stock Data

97.44M
2.37M
71.73%
0.9%
0.19%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
MONROVIA